In general, the IP was defined according to the AASLD 2018 guidance in this meta-analysis, but because the existing literature lacks relevant IP studies, we did not strictly follow the criteria of normal ALT defined by the AASLD 2018 guideline. The gene discussed is GPT; the disease is incontinentia pigmenti.